FTC sues significant pharmacy advantage supervisors in excess of insulin price ranges The company introduced action from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of lifestyle-conserving insulin medications. Sanders quickly condemned the go in a statement Wednesday, noting he https://kameronqhype.wizzardsblog.com/30647618/how-much-you-need-to-expect-you-ll-pay-for-a-good-healthcare-news